Press releases and financial reports
In the CombiGenes pressroom you will find press releases, newsletters, and the latest reports. High resolution images as well as logos are available for use in articles and in newsstands.
Copyright applies to all footage.
Read, among other things, how CombiGene takes the next big step towards clinical trialsread more
CombiGene: Now we’re strengthening our management team with the addition of Karin Agerman as Chief Research & Development Officer.
During 2018 CombiGene is entering a decisive phase with focus on development of a manufacturing method for our candidate drug, CG01, and continued intensive business development. This will demand a good measure of professionalism and expertise, as well as...read more
The preference share issue, realized during the period 12 February – 28 February 2018, was subscribed to 22.5 percent, 79 percent of which was subscribed with subscription rights. The issue raised 2.3 million kronor in issue capital before issuing expenses...read more
CombiGene had a very intensive year in 2017, with three successful preclinical studies. Thanks to the positive results from these studies, CombiGene is now preparing for the next important step on our path to an approved drug via our collaboration with...read more
Find it easy
"This is an English translation of the Swedish website; if there is any inconsistency or ambiguity between the English version and the Swedish version, the Swedish version shall prevail. For a complete list of regulatory-related press releases, please refer to the Swedish website"